Périé Sophie, Fessi Hafedh, Tassart Marc, Younsi Nassima, Poli Isabelle, St Guily Jean Lacau, Talbot Jean-Noël
Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine Saint Antoine, University Paris VI, Hospital Tenon, Paris, France.
Am J Kidney Dis. 2005 Feb;45(2):344-52. doi: 10.1053/j.ajkd.2004.10.021.
The usefulness of both dual-phase dual-isotope iodine 123 ( 123 I)/technetium Tc 99m ( 99m Tc) sestamibi scintigraphy and ultrasonography for the detection of hyperplastic parathyroid glands secondary to renal hyperparathyroidism is rarely addressed; most studies focus on primary hyperparathyroidism. However, it may be crucial to identify and accurately localize hyperplastic glands before surgery.
To study the usefulness of high-resolution ultrasonography (performed by both the radiologist and surgeon) and dual-phase dual-isotope 123 I/ 99m Tc sestamibi scintigraphy in patients with renal hyperparathyroidism, a series of 20 patients consecutively referred for parathyroidectomy was studied prospectively. Results of both examinations, independently scored, were correlated with surgical and histopathologic findings for each hyperplastic parathyroid gland localization.
All parathyroid glands except 1 were found during primary surgery consisting of a subtotal parathyroidectomy (success rate, 99%). The missed gland was removed successfully 1 month later. Neither supernumerary nor ectopic glands were found. Mean weight of totally removed parathyroid glands was 633 mg. Ultrasonography detected 75% of hyperplastic parathyroid glands; dual-phase 123 I/ 99m Tc sestamibi scintigraphy, 66%; and a combination of both, 88%. Most missed glands at scintigraphy corresponded to superior glands, whereas false-negative results at ultrasonography correlated with low gland weight.
Combined ultrasonography and 123 I/ 99m Tc sestamibi scintigraphy should be considered for routine use to localize hyperplastic parathyroid glands in patients with renal hyperparathyroidism undergoing surgery. We suggest performing scintigraphy first, before ultrasonography, to guide the radiologist to areas of hyperfunctioning glands. In our experience, this proved very helpful in achieving a high surgical success rate in patients with renal hyperparathyroidism, especially when the surgeon visualizes the parathyroid glands at ultrasonography.
双相双同位素碘123(¹²³I)/锝Tc 99m(⁹⁹ᵐTc)甲氧基异丁基异腈闪烁扫描术和超声检查在检测肾性甲状旁腺功能亢进继发的增生性甲状旁腺方面的实用性很少被提及;大多数研究集中在原发性甲状旁腺功能亢进。然而,在手术前识别并准确定位增生性腺可能至关重要。
为研究高分辨率超声检查(由放射科医生和外科医生共同进行)和双相双同位素¹²³I/⁹⁹ᵐTc甲氧基异丁基异腈闪烁扫描术在肾性甲状旁腺功能亢进患者中的实用性,前瞻性研究了连续转诊接受甲状旁腺切除术的20例患者。对两项检查结果分别进行评分,并与每个增生性甲状旁腺定位的手术和组织病理学结果相关联。
在包括次全甲状旁腺切除术的初次手术中,除1个甲状旁腺外,其余所有甲状旁腺均被发现(成功率为99%)。1个月后成功切除了遗漏的甲状旁腺。未发现多余或异位的腺体因素。完全切除的甲状旁腺平均重量为633毫克。超声检查检测出75%的增生性甲状旁腺;双相¹²³I/⁹⁹ᵐTc甲氧基异丁基异腈闪烁扫描术检测出66%;两者联合检测出88%。闪烁扫描术中大多数遗漏的腺体对应于上位腺体,而超声检查的假阴性结果与腺体重量低相关。
对于接受手术的肾性甲状旁腺功能亢进患者,应考虑联合使用超声检查和¹²³I/⁹⁹ᵐTc甲氧基异丁基异腈闪烁扫描术来定位增生性甲状旁腺。我们建议在超声检查之前先进行闪烁扫描术,以引导放射科医生找到功能亢进腺体的区域。根据我们的经验,这对于提高肾性甲状旁腺功能亢进患者的手术成功率非常有帮助,尤其是当外科医生在超声检查中可视化甲状旁腺时。